2 Information about obinutuzumab
2.3 £3,312 per 1,000‑mg vial (excluding VAT; BNF online, August 2017). The company has a commercial arrangement. This makes obinutuzumab available to the NHS with a discount. The size of the discount is commercial in confidence. It is the company's responsibility to let relevant NHS organisations know details of the discount.